Skip to main content
Clinical Trials/NCT04421066
NCT04421066
Completed
Not Applicable

Histological, Genetic and Epigenetic Analysis of Procedures Related with Dental Implants

Simón Pardiñas López1 site in 1 country200 target enrollmentJanuary 29, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peri-Implantitis
Sponsor
Simón Pardiñas López
Enrollment
200
Locations
1
Primary Endpoint
Differences in epigenetic characteristics analyzing DNA methylation in peri-implantitis subjects compared to healthy subjects.
Status
Completed
Last Updated
last year

Overview

Brief Summary

In this study genomic, proteomic and histological technologies for the search and characterization of epigenetic modifications and molecular or protein markers, useful in the diagnosis and progression of peri-implant diseases and prevention of implant failure will be used.

Detailed Description

Samples stored at the Biomedical Research Institute of A Coruña, Xerencia Integrated Management of A Coruña (University Hospital Center of A Coruña), belonging to the collection of the line of research "Oral Health and Systemic Relationship" with registration nº 2017/104 will be used for the realization of the present study. Nucleic acid extraction and histological analysis of the samples will be performed to evaluate the functional epigenetic modifications associated with peri-implant diseases, in an exploratory manner.

Registry
clinicaltrials.gov
Start Date
January 29, 2019
End Date
June 20, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Simón Pardiñas López
Responsible Party
Sponsor Investigator
Principal Investigator

Simón Pardiñas López

Director

Fundacion Clinica Pardinas

Eligibility Criteria

Inclusion Criteria

  • The subjects must have read, understood and signed an informed consent regarding the obtaining of biological samples and participation in the research line of "Oral Health and Systemic Relationship" existing in the Pardiñas Dental Medical Clinic and approved by the ethical committee.
  • The subjects must be between 20-90 years of age.
  • Subjects must be non-smokers or former smokers who have quit smoking for at least one year prior to enrollment in the study.
  • In addition to the general criteria listed, samples of a healthy periodontal subject must meet the following criteria when reviewing their medical and dental history :
  • Subjects do not have or have had a history of periodontal disease, as described in the " 2017 World Workshop on the Classification of Periodontal and Peri- Implant Diseases and Conditions "
  • Samples from a subject with peri-implant disease must meet the following criteria:
  • Samples of subjects who have at least one implant - supported prosthesis for at least 12 months and affected by peri- implant disease according to the " 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions "

Exclusion Criteria

  • Samples of pregnant or lactating women at the time of collection.
  • Samples of subjects who were taking antibiotics within 1 month before collection of the sample.
  • Samples of subjects with chronic use of non-steroidal anti-inflammatory drugs for more than 3 weeks at the time of sample collection. The use of aspirin in low doses (≤81 mg / day) will be allowed .
  • Samples from subjects with disease in the mucosa in the area located around the site of sample collection.
  • Samples of subjects with a systemic disease that would exclude the analysis (for example, severe medical problems, bone metabolism disorders, uncontrolled bleeding disorders, depressed immune system, diseases that require the periodic use of steroids, uncontrolled endocrine disorders) .
  • Samples of subjects with a history of local irradiation therapy in the head / neck area.
  • Samples of subjects with a history of having received treatment with intravenous or subcutaneous antiresorptive agents associated with osteonecrosis of the jaw, such as bisphosphonates.
  • Samples of subjects assigned to the healthy group that meet any of the following criteria will be excluded from participation in this study:
  • Root fragments, pericoronaritis, endo-perio lesions, dental abscesses at the site of the biopsy.
  • Presence of BOP in the sample collection site.

Outcomes

Primary Outcomes

Differences in epigenetic characteristics analyzing DNA methylation in peri-implantitis subjects compared to healthy subjects.

Time Frame: 1 day

Gingival and blood samples collected from healthy subjects and subjects with peri-implantitis (including failing implants) will be used to determinate epigenetic characteristics associated with peri-implantitis.

Differences in histological characteristics in peri-implantitis subjects compared to healthy subjects, ie, presence and amount of inflammatory cells and bacteria.

Time Frame: 1 day

Gingival and blood samples collected from healthy subjects and subjects with peri-implantitis (including failing implants) will be used to determinate histological characteristics associated with peri-implantitis.

Secondary Outcomes

  • Relation between peri-implant diseases and epigenetic modifications in terms of clinical attachment level.(1 day)
  • Patient-reported outcome measures.(1 day)
  • Relation between peri-implant diseases and epigenetic modifications in terms of periodontal pocket depth.(1 day)
  • Relation between peri-implant diseases and epigenetic modifications in terms of bleeding on probing.(1 day)
  • Relation between peri-implant diseases and epigenetic modifications in terms of plaque index.(1 day)

Study Sites (1)

Loading locations...

Similar Trials